Home/Filings/4/0001209191-07-029583
4//SEC Filing

LA JOLLA PHARMACEUTICAL CO 4

Accession 0001209191-07-029583

CIK 0000920465operating

Filed

May 10, 8:00 PM ET

Accepted

May 11, 2:12 PM ET

Size

5.9 KB

Accession

0001209191-07-029583

Insider Transaction Report

Form 4
Period: 2007-05-10
CAVIAR NIV EDWARD
Chief Business Officer & CFO
Transactions
  • Award

    Stock Option (right to buy)

    2007-05-10+180,000180,000 total
    Exercise: $5.36Exp: 2017-05-10Common Stock (180,000 underlying)
Footnotes (1)
  • [F1]The stock options vest and become exercisable with respect to 25% of the underlying shares on 05/10/2008 and thereafter ratably on a monthly basis over the next 3 years.

Issuer

LA JOLLA PHARMACEUTICAL CO

CIK 0000920465

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000920465

Filing Metadata

Form type
4
Filed
May 10, 8:00 PM ET
Accepted
May 11, 2:12 PM ET
Size
5.9 KB